Financials
- Market Capitalization 1.29 B
- Employee 489
- Founded 2007
- CEO Mike Raab
- Website www.ardelyx.com
- Headquarter Delaware, United States
- FIGI BBG001WH4DQ3
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-24.96
ratio cours/chiffre d'affaires
3.39
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2257 | NVAX Novavax, Inc. - Common Stock | 8.33 USD | -1.07% | -10.81% | -9.65% | +20.38% | 1.37 B USD | ||
| 2260 | INBX Inhibrx Biosciences, Inc. - Common Stock | 93.13 USD | -0.09% | -2.50% | +0.12% | +15.57% | 1.37 B USD | ||
| 2307 | IMTX Immatics N.V. - Ordinary Shares | 9.50 USD | +1.60% | -4.52% | +0.85% | -8.21% | 1.27 B USD | ||
| 2313 | CRVS Corvus Pharmaceuticals, Inc. - Common Stock | 15.05 USD | +0.53% | -5.94% | +21.67% | +260.91% | 1.27 B USD |